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We studied a commensal colistin-resistant Escherichia coli isolated from a swine cecum
sample collected at a slaughter, in Portugal. Antimicrobial susceptibility phenotype of
E. coli LV23529 showed resistance to colistin at a minimum inhibitory concentration
of 4 mg/L. Whole genome of E. coli LV23529 was sequenced using a MiSeq system
and the assembled contigs were analyzed for the presence of antibiotic resistance
and plasmid replicon types using bioinformatics tools. We report a novel mcr-1 gene
variant (mcr-1.9), carried by an IncX4 plasmid, where one-point mutation at nucleotide
T1238C leads to Val413Ala substitution. The mcr-1.9 genetic context was characterized
by an IS26 element upstream of the mcr-pap2 element and by the absence of
ISApl1. Bioinformatic analysis also revealed genes conferring resistance to β-lactams,
sulphamethoxazole, trimethoprim, chloramphenicol and colistin, corresponding to the
phenotype noticed. Moreover, we highlight the presence of mcr-1.9 plus blaCTX-M-8,
a blaESBL gene rarely detected in Europe in isolates of animal origin; these two
genes were located on different plasmids with 33,303 and 89,458 bp, respectively.
MCR-1.9-harboring plasmid showed high identity to other X4-type mcr-1-harboring
plasmids characterized worldwide, which strongly suggests that the presence of PMCR-
encoding genes in food-producing animals, such as MCR-1.9, represent a potential
threat to humans, as it is located in mobile genetic elements that have the potential to
spread horizontally.
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INTRODUCTION
Since the report of a plasmid-mediated colistin resistance (PMCR) mechanism, designated MCR-1,
in Escherichia coli and Klebsiella pneumoniae isolated from animals, food and humans in China,
further reports exposed the global dissemination of mcr-type gene in various bacterial species
isolated from a wide range of different sources (Caniaux et al., 2017). In Portugal, PMCR has also
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been detected in a wide range of different sources and species,
including humans, food-producing animals and meat, and in
the environment (Campos et al., 2016; Figueiredo et al., 2016;
Jones-Dias et al., 2016; Kieffer et al., 2017; Manageiro et al.,
2017; Tacão et al., 2017; Mendes et al., 2018). Noteworthy,
are the recent report of two cases presumably associated with
the travel of patients from Portugal, one involving animals: a
patient repatriated to France after hospitalization for 2 months in
Portugal, in 2015 (Beyrouthy et al., 2017), and a New York state
patient returning from Portugal in 2016 after staying on a farm
with chickens and pigs (Gilrane et al., 2017).
More worrisome is the presence of mcr genes in
Enterobacteriaceae carrying other resistance determinants
namely, extended-spectrum β-lactamases (ESBL)- and/or
carbapenemase-encoding genes. Since the first report of co-
localization of mcr-1 and ESBL- in 2016 in bovines in France,
an increase encoding genes in the proportion of mcr-1 genes
among ESBL-producing E. coli in animals has been noticed,
suggesting that the use of extended-spectrum cephalosporins
may have simultaneously favored the spread of mcr-1 (Haenni
et al., 2016). Here we describe the first detection of a novel mcr
variant, hereafter-named mcr-1.9, identified in a commensal
E. coli LV23529 isolated from a swine cecum sample collected at
a slaughter, in Portugal.
MATERIALS AND METHODS
Bacterial Isolate
Escherichia coli LV23529 was isolated in 2015 from a swine cecum
sample collected at a Portuguese slaughter, during an evaluation
study of commensal E. coli recovered from swine samples for
antimicrobial susceptibility testing.
Antimicrobial Susceptibility Testing
Minimum inhibitory concentrations (MICs) were determined
by microdilution method as previously described (Manageiro
et al., 2017). In order to assess decreased susceptibility of the
strain, interpretation of the results was done according to the
epidemiological cut-off values recommended by the European
Committee on Antimicrobial Susceptibility Testing (EUCAST1).
Screening and Characterization of
PMCR- and ESBL-Resistance
Mechanisms
Molecular Detection of mcr-1 and blaESBL-Encoding
Genes
Following phenotypic characteristics, PMCR- and ESBL-
resistance mechanisms were searched and identified by molecular
methods, as previously described (Manageiro et al., 2017).
Transfer Experiments
Conjugation experiments were performed using sodium azide-
resistant E. coli J53 as a recipient strain. Transconjugants
1http://mic.eucast.org/Eucast2/
were selected on McConkey agar supplemented with sodium
azide (150 mg/L) and either cefotaxime (2 mg/L) or colistin
(2 mg/L). Plasmid DNA was extracted from E. coli LV23529
using a NucleoBond Xtra Plus kit (Macherey-Nagel), and
transformed into E. coli TOP10 OneShot chemically competent
cells (Invitrogen), accordingly to manufacture’s protocol. E. coli
transformants were selected on MacConkey agar supplemented
with 2 mg/L of colistin. PCR for blaCTX-M-8 or mcr-1-type
and MICs of recipients and transformants were determined as
mentioned above.
Genetic Context of mcr-1.9 Gene
Colistin-resistant E. coli LV23529 was genotypically characterized
by whole-genome sequencing (WGS), as previously described
(Manageiro et al., 2017). Sequence reads were trimmed and
filtered according to quality criteria, and de novo assembled
into contigs by means of CLC Genomics Workbench 10.0
(Qiagen). The assembled contigs were analyzed and studied
for the presence of antibiotic resistance, virulence genes and
plasmid replicon types, serotype, multi-locus sequence type
(ST) and fim-type, using bioinformatics tools2. The NCBI
prokaryotic genome automatic annotation pipeline (PGAAP)
was used for annotation.
Plasmid sequencing was also performed on a MiSeq Illumina
platform using 150 bp paired-end reads, after plasmid DNA
extraction from TLV23529 (mcr-1.9) using a NucleoBond Xtra
Plus kit (Macherey-Nagel), and quantification using Qubit 1.0
Fluorometer (Invitrogen), as previously described (Manageiro
et al., 2017). Sequence reads were trimmed and filtered
according to quality criteria, and mapped against E. coli ATCC
25922 genome (NZ_CP009073). Unmapped reads (80.2%/total
reads) were then used for plasmids structure construction
by mapping assembly based on the genetic organization of
the closest plasmid sequences obtained by BLASTn; this
was followed by contig neighbor’s prediction from assembly
information using CLC Genomics Workbench 10.0 (Qiagen).
NCBI Microbial genomes BLAST analysis tool3 was used
to search for plasmid sequences. Plasmid alignments and
ORF representations were also done using EasyFig v. 2.2.3
(Sullivan et al., 2011).
Genomic Epidemiological Analysis
BacWGSTdb database was used for genotyping and source
tracking bacterial pathogen (Ruan and Feng, 2016).
Nucleotide Sequence Accession Number
The pLV23529-MCR-1.9 and pLV23529-CTX-M-8 nucleotide
sequences from this study were submitted to the NCBI GenBank
Database with accession numbers KY964067 and KY964068,
respectively. The new mcr-1.9 nucleotide sequence was submitted
with accession number KY780959.
This Whole Genome Shotgun project has been deposited at
DDBJ/ENA/GenBank under the accession SBIH00000000. The
version described in this paper is version SBIH01000000.
2https://cge.cbs.dtu.dk/services/
3https://www.ncbi.nlm.nih.gov/genome/microbes/
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RESULTS AND DISCUSSION
MIC results showed that LV23529 was non-wild-type to
third- and fourth-generation cephalosporins (ceftazidime
2 mg/L, cefotaxime 32 mg/L, cefepime 8 mg/L) with synergy
with clavulanic acid; this isolate was also non-wild-type
to chloramphenicol (>128 mg/L), sulphamethoxazole
(>1024 mg/L), trimethoprim (>32 mg/L), tetracycline
(>64 mg/L), and colistin (4 mg/L). LV23529 remained wild-
type to carbapenems, fluoroquinolones, aminoglycosides and
tigecycline (Table 1).
Molecular characterization of the E. coli LV23529 isolate
allowed the detection of blaCTX-M-8 and mcr-1-type genes.
Only the transferability of the blaCTX-M-8 gene was achieved
by conjugation, with TcLV23529 (blaCTX-M-8) exhibiting the
ESBL phenotype from LV23529 isolate (cefotaxime 2 mg/L,
cefepime 2 mg/L) with synergy with clavulanic acid, and wild-
type to colistin (≤1 mg/L) (Table 1). Although conjugation
assays for mcr-1-type were negative, the colistin resistance
determinant could be transferred to E. coli TOP10 competent
cells; transformant TLV23529 (mcr-1-type) showed the respective
resistance to colistin (4 mg/L) (Table 1).
The WGS assembly of E. coli LV23529 yielded 193
contigs (average 143.7-fold coverage), which together comprised
5,122,415bp, showing a GC content of 50.7%. The largest
contig was 320,931 bp long; the N50 statistic, which stands
for the minimum contig length of at least 50% of the contigs,
was 113,197 bp. The average length of the obtained contigs
was 26,541 bp. Overall, the genome sequence comprised
5,124 putative genes, among which 5,037 consisted of protein
encoding sequences.
The WGS analysis showed that E. coli LV23529 belongs
to serotype O8:H19, usually associated with porcine stx2e-
producing E. coli (Zweifel et al., 2006; Bai et al., 2015),
and to MLST (Achtman scheme) ST201 [clonal complex 469
(CC469)] and to the FimH-type determinant fimH32. This
ST201 was encountered worldwide mainly in isolates collected
from livestock samples (Escherichia/Shigella Enterobase database,
Alikhan et al., 2018). Three virulence factors were detected:
astA (heat-stable enterotoxin 1), lpfA (long polar fimbriae), and
gad-type (glutamate decarboxylase).
Further bioinformatics analysis of E. coli LV23529 isolate
revealed acquired-genes conferring resistance to β-lactams
(blaCTX-M-8 and blaTEM-1), aminoglycosides (aadA1 and aadA2),
TABLE 1 | Phenotypic and genotypic context of CTX-M-8 and MCR-1.9 producing E. coli clinical isolate, transformant, transconjugant, and the respective recipient
strains.
Antibiotic LV23529b Transformation Conjugation
(blaCTX-M-8, mcr-1.9,
cmlA1, sul3, tetA,
tetM, dfrA12, aadA1,
aadA2)
E. coli TOP10c TLV23529d
(mcr-1.9)
ECJ53AZNae TcLV2352f
(blaCTX-M-8)
Ampicillin >64 4 8 2 >64
Cefoxitine 4 4 4 4 8
Ceftazidime 2 0.5 0.5 ≤0.5 1
Ceftazidime plus clavulanatea ≤0.125/4 0.5 0.5 ≤0.125/4 ≤0.25/4
Cefotaxime 32 ≤0.25 ≤0.25 ≤0.25 2
Cefotaxime plus clavulanatea ≤0.06/4 0.125 0.125 ≤0.06/4 ≤0.06/4
Cefepime 8 0.125 0.125 ≤0.06 2
Imipenem 0.25 0.5 0.5 0.25 0.25
Meropenem ≤0.03 0.06 0.06 ≤0.03 ≤0.03
Ertapenem ≤0.015 ≤0.015 ≤0.015 ≤0.015 ≤ 0.015
Nalidixic acid ≤4 ≤4 ≤4 ≤4 ≤4
Ciprofloxacin ≤0.015 ≤0.015 ≤0.015 ≤0.015 ≤0.015
Chloramphenicol >128 ≤8 ≤8 ≤8 ≤8
Sulphamethoxazole >1024 ≤8 ≤8 ≤8 ≤8
Tetracycline >64 ≤2 ≤2 ≤2 ≤2
Trimethoprim >32 ≤0.25 ≤0.25 ≤0.25 ≤0.25
Gentamicin ≤0.5 ≤0.5 ≤0.5 ≤0.5 ≤0.5
Colistin 4 ≤1 2 ≤1 ≤1
Tigecycline ≤0.25 ≤0.25 ≤0.25 ≤0.25 ≤0.25
MICs in mg/L.
aClavulanate 4 mg/L.
bE. coli LV23529 was the clinical isolate harboring the acquired antibiotic resistance genes blaCTX-M-8, mcr-1.9, cmlA1, sul3, tetA, tetM, dfrA12, aadA1, and aadA2.
cE. coli TOP10 was the recipient strain in the transformation experiment.
dTLV23529 is a transformant of LV23529 (harboring mcr-1.9).
eE. coli J53AZNa was the recipient strain in the conjugation experiment.
fTcLV23529 is a transconjugant of LV23529 (harboring blaCTX-M-8).
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FIGURE 1 | Linear comparison of IncX4-pLV23529-MCR-1.9 with the top six mcr-1-harboring plasmids showing the highest identities (>99.9%, E-value 0.0), in
different E. coli isolates. Boxed arrows represent the position and transcriptional direction of ORFs. Gray vertical blocks indicate the shared similarity regions
according to TBLASTX identity. Genes associated with pilus and plasmid transfer are colored yellow, antibiotic resistance genes are colored red, mobile genetic
elements are colored pink, and other genes are colored gray (hypothetical proteins) or blue (other).
FIGURE 2 | Schematic representation of the genetic environment of mcr-1.9 in comparison with other mcr-1-type representative environments. Boxed arrows
represent the position and transcriptional direction of ORFs. Genes are not drawn to scale. Genes associated with pilus and plasmid transfer are colored yellow,
antibiotic resistance genes are in red, mobile genetic elements in pink, plasmid maintenance and stability genes in violet, plasmid replication associated genes are in
light blue, and other genes are colored gray (hypothetical proteins) or blue (other).
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FIGURE 3 | Schematic maps of pLV23529-MCR-1.9 (A) and pLV23529-CTX-M-8 (B). Genes are denoted by arrows and colored based on gene function
classification.
TABLE 2 | Comparison of IncX4-pLV23529-MCR-1.9 with the top six mcr-1-harboring plasmids showing the highest identities (>99.9%, E-value 0.0), in different E. coli
isolates.
IncX4-type Plasmid
(bp)
E. coli strain (MLSTa) Source/Country/Year Identity
(%)
Mismatches/
gap opens
(No. of
nucleotides)
Query
alignment
overlap
(%)
pLV23529-
MCR-1.9
Alignment
overlap
(%)
Plasmid
GenBank
Acc. No.
pMCRpoa (33,511) 3431F (ST744) Human patient/Brazil/2014 99.98 15/1 99.4 100.0 CM007714
pl4EC007a (35,098) 14Ec007 (ST301) Human patient/China/2014 99.98 15/1 94.9 100.0 CP024132
pMCR-1-NY (33,304) MDR56 (ST117) Human patient /United States/2015 99.97 19/1 100.0 100.0 CP019908
pICBEC72Hmcr
(33,304)
ICBEC72H (ST101) Human patient/Brazil/2016 99.95 17/0 100.0 100.0 CP015977
pl4EC033b (33,301) 14EC033 (ST2064) Human patient/China/2014 99.92 16/3 100.0 100.0 CP024149
pICBEC7Pmcr
(34,992)
ICBEC7P (ST10) Magellanic penguins/Brazil/2013 99.92 16/3 95.2 100.0 CPO17246
aMLST accordingly with Warwick scheme (http://mlst.warwick.ac.uk/mlst/dbs/Ecoli).
phenicol (cmlA1-type and floR-type), sulphamethoxazole
(sul3), tetracycline [tet(A)-type and tet(M)-type], trimethoprim
(dfrA12), and colistin (mcr-1-type), justifying the phenotype
noticed. Additionally, several unknown mutations in the
ampC (promoter region), parC, 16S rrsB, 16S rrsC, 23S and
pmrB chromosomal genes were detected, the last gene being
described as the primary mechanism for the development
of chromosomally encoded resistance to polymyxins
(Phan et al., 2017).
The named mcr-1.9, differed from mcr-1 by one-point
mutation (T1238C), leading to Val413Ala substitution. The
MCR-1 protein contains a transmembrane domain and a
phosphoethanolamine (PEA) transferase domain with 8α, 12β,
and 12η units (Gao et al., 2016). The amino acid substitution
of MCR-1.9 occurred in the region between η7 e η8 of the PEA
transferase domain, which have been found not to influence the
function of MCR-1 (Gao et al., 2016).
The mcr-1.9 genetic context was characterized by an IS26
element upstream of the mcr-pap2 element and by the absence
of ISApl1 (Figure 1), which is in accordance with other studies
about mcr-1 gene (Veldman et al., 2016; Sun et al., 2017).
The mcr-1.9 gene can be mobilized within an ISApl1-flanked
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composite transposon (Tn6330), although many sequences have
been identified without ISApl1 or with just a single copy (Snesrud
et al., 2018). Indeed, it has been described that initially ISApl1 was
presumably involved in the transposition of the mcr-1 cassette
and then was lost, contributing for the stability of mcr gene on
IncX4 plasmids (Sun et al., 2017; Snesrud et al., 2018).
The PMCR-encoding gene was found in an IncX4 plasmid
(pLV23529-MCR-1.9), showing highest identities (>99.9%) with
six IncX4-type mcr-1-harboring plasmids identified worldwide,
in unrelated E. coli isolates, mainly collected from human patients
(Figure 2 and Table 2). Indeed, all belonged to different MLST,
which might suggest a resistance plasmid dissemination across
strains (plasmid outbreak) rather than clonal transmission of
MCR-1-type-producing strains. Furthermore, no E. coli LV23529
closely related isolates were detected among those currently
deposited in the public database BacWGSTdb (Ruan and Feng,
2016), which reinforce the importance of the horizontal gene
transfer in this study.
Like pLV23529-MCR-1.9, the six plasmids (Table 2) doesn’t
have the ISApl1 element. Hence, similarities may suggest that
the one-point mutation (T1238C) in mcr-1.9 occurred on the X4
plasmid, since mobilization of mcr-1 occurs as part of a composite
transposon (Tn6330) and that structures lacking the downstream
ISApl1 are not capable of mobilization (Snesrud et al., 2018).
The IS26 upstream of the mcr-pap2 element is flanked by
an 8bp direct repeat (Figure 3A), indicating that its insertion
wouldn’t seems to be related to the mcr-1.9 context, justifying the
differences found with other IncX4 mcr-1-harboring plasmids.
IncX4 plasmid has been widely implicated in the spread of
MCR-1 gene in Europe (Caniaux et al., 2017). In Portugal, this
plasmid type is circulating among diverse hosts (humans, pigs,
poultry), being responsible for hospital-based outbreak caused
by MCR-1 plus KPC-3-producing K. pneumoniae (Mendes et al.,
2018), as well as for the diffusion of this PMCR at the farm
level (Kieffer et al., 2017). Indeed, IncX4 plasmids seem to be
efficiently transferred at different temperatures and different lack-
of-fitness burdens among bacterial hosts, which may facilitate
the transfer of mcr-type among Enterobacteriaceae (Lo et al.,
2014; Wu R. et al., 2018). The pLV23529-MCR-1.9 plasmid
backbone contains all the core genes common to IncX plasmids
involved in segregation, stability, replication, and conjugative
transfer of the plasmid (Figure 3A), namely the IncX-type pilus
synthesis operon (pilX1-pilX11). However, pLV23529-MCR-1.9
was mobilizable, but not self-transmissible. Of note, we found a
one-point mutation (G64T), leading to Asp22Tyr substitution,
in the PilX1, a peptidoglycan hydrolase involved in T-DNA
plasmid transfer. This mutation might explain why the attempts
to conjugate mcr-1.9 from E. coli LV23529 were unsuccessful
(Chen et al., 2009).
Further plasmid analysis revealed the presence of two
other plasmids: IncF [F2:A-:B-], IncR and the colicinogenic
IncI1-ST113-carrying the blaCTX-M-8 (pLV23529-CTX-M-8,
Figure 3B). Of note, the mcr-1.9-positive isolate, co-harboring
blaCTX-M-8 and blaTEM-1 genes, is here reported for the first
time in an E. coli isolate of animal origin. In fact, blaCTX-M-8
gene is rarely detected in Europe in isolates of animal origin
(Börjesson et al., 2016), but in humans seems to be emerging
(Eller et al., 2014). Indeed, a recent phylogenetic study suggested
an increasing trend of co-existence and transmission of blaCTX-M
and mcr-1 in both clinical medicine and veterinary medicine
(Wu C. et al., 2018).
In conclusion, the presence of PMCR-encoding genes, such as
MCR-1.9, in food-producing animals represents a potential threat
to humans, as it is located in mobile genetic elements that have
the potential to spread horizontally. As mentioned, in Portugal,
PMCR is an emerging problem and its international spread is a
worrying reality (Beyrouthy et al., 2017; Gilrane et al., 2017).
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